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Abstract
Background: Rapid reviews (RRs) have emerged as an efficient alternative to time-consuming systematic reviews—
they can help meet the demand for accelerated evidence synthesis to inform decision-making in healthcare. The
synthesis of diagnostic evidence has important methodological challenges. Here, we performed an international
survey to identify the current practice of producing RRs for diagnostic tests.
Methods: We developed and administered an online survey inviting institutions that perform RRs of diagnostic
tests from all over the world.
Results: All participants (N = 25) reported the implementation of one or more methods to define the scope of the
RR; however, only one strategy (defining a structured question) was used by ≥90% of participants. All participants
used at least one methodological shortcut including the use of a previous review as a starting point (92%) and the
use of limits on the search (96%). Parallelization and automation of review tasks were not extensively used (48 and
20%, respectively).
Conclusion: Our survey indicates a greater use of shortcuts and limits for conducting diagnostic test RRs versus the
results of a recent scoping review analyzing published RRs. Several shortcuts are used without knowing how their
implementation affects the results of the evidence synthesis in the setting of diagnostic test reviews. Thus, a
structured evaluation of the challenges and implications of the adoption of these RR methods is warranted.
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Background
Rapid reviews (RRs) have emerged as an efficient alter-
native to resource-intensive systematic reviews (SRs).
RRs can speed up evidence synthesis by implementing
methods and strategies to streamline the review process
[1–4]. RRs can inform best practices for a diverse variety
of clinical and public health topics requiring a quick
turnaround [5–7]. Examples of topics where RRs are
susceptible to be used to provide timely evidence include
the identification of challenges to disease surveillance in
the context of the crisis in Syria, the impact of e-health
for rural residents in Australia and the adequate man-
agement of new emergent diseases as the COVID-19 dis-
ease [8–10].
The methods for performing systematic reviews are
now well established for the field of medical test accur-
acy as with other areas of healthcare [11]. For diagnostic
accuracy reviews, key characteristics include clearly-
stated objectives and eligibility criteria; a systematic lit-
erature search; an assessment of methodological quality;
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and a systematic synthesis and presentation of the find-
ings from the included studies [11–14]. In response to
the demand for accelerated evidence syntheses to inform
clinical decisions and policy, efforts have been made to
standardize the methods and strategies for carrying out
RRs while often extrapolating from effectiveness and
safety RRs [4, 6, 7, 15, 16]. The RRs of diagnostic evi-
dence however, present particular challenges given the
fundamental differences between the methods used to
summarize the evidence for interventions and those for
diagnostic evidence. For instance, in contrast to SRs of
interventions, SRs of diagnostic accuracy identify eligible
studies from electronic search strategies that often in-
volve screening thousands of titles and abstracts. The
use of methodological filters can limit the volume of ci-
tations retrieved and is strongly discouraged [17, 18].
Moreover, in diagnostic accuracy SRs, the synthesis of
evidence requires statistical knowledge to fit the com-
plex statistical models needed for conducting meta-
analyses [11, 12, 19].
In a previous scoping review, we examined the charac-
teristics of RRs of diagnostic tests by scrutinizing reposi-
tories of Health Technology Assessment (HTA) agencies
and papers published in indexed journals [20]. We found
191 RRs developed by international agencies since
2013—there was a clear increase better and more rapid
synthesis of diagnostic evidence. We also observed that
most RRs were broad in scope and assessed multiple
index tests, outcomes, and test applications. We further
found that well-known methodological tailoring strat-
egies such as setting limits for literature searching by
date, language, or number of databases were rarely re-
ported. Due to an incomplete description of the methods
used in the RRs, as well as inclusion of only published
reports, we could not provide a detailed account of the
current practice for the development of RRs of diagnos-
tic tests [20]. To better understand how RR methods are
currently used to synthesize diagnostic evidence, we per-
formed an international survey to identify methodo-
logical practices used in the development of RRs for
diagnostic tests.
Methods
We developed and administered an online questionnaire
seeking information about the methods and resources
involved in the performance of RRs of diagnostic tests.
We published a protocol summarizing the methods used
to conduct this survey [21]. We followed the Checklist
for Reporting Results of Internet E-Surveys (CHERRIES)
guidance to report the findings of our research [22].
Design of the survey
We developed and administered our questionnaire using
SurveyMonkey software (https://surveymonkey.com/). We
defined RR as “a knowledge synthesis strategy using lim-
ited or accelerated methods to expedite the time required
to obtain a conclusive answer” [6]. In addition, we defined
a diagnostic test as “any method for collecting additional
information about the current or future health status of a
patient” [23].
The questions in our survey focused on the method-
ology that responders use to conduct RRs, and drew on
those elements that we previously identified in our scop-
ing review [5, 20] including methods to:
a. limit the scope of the review question (narrow the
scope)
b. focus on methodological tailoring of review steps
according to the needs of decision-makers (review
shortcuts)
c. increase the intensity of the work on review
processes (parallelization of tasks)
d. use new technologies to fast-track selected review
tasks (automation)
To gauge the level of experience and skills of the team,
we included questions about the number of RRs of diag-
nostic tests previously conducted, the structure of the
review team, and strategies for completing and publish-
ing the final report.
We developed several drafts of the questionnaire prior
to finalizing a pilot version. The pilot was tested by five
researchers external to the research team who were
asked to assess the usability and technical functionality
of the survey. After this revision, the final version of the
questionnaire consisted of 10 items: Six were multiple-
choice questions, and four were open answers. A copy of
the survey is available as a supplementary file.
Recruitment process and description of the sample
On April 2019, we invited representatives from institu-
tions around the world who perform evidence syntheses
to participate in this closed survey. The invited represen-
tatives were from institutions belonging to the Inter-
national Network of Agencies for Health Technology
Assessment (INAHTA), the World Health Organization
(WHO) collaborating centers on Health Technology As-
sessment (HTA), the Health Technology Assessment
Network of the Americas (REDETSA), and the Health
Technology Assessment International Network (HTAi,
non-profit members).
All initial contacts were made by the principal investi-
gator; participants were invited via an email message
that included a personal invitation letter and a copy of
the research protocol [21]. In addition, we provided a
participant information sheet with details regarding the
purpose of the study, reasons for their invitation, proce-
dures involved in participation, as well as privacy and
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confidentiality processes. Participating institutions were
asked to nominate a member of the team with experi-
ence in developing RRs to complete the survey.
Four reminders were sent by email to non-responders
every 3 weeks until we closed the survey in July 2019.
Participation in the survey was voluntary, and partici-
pants could leave the study at any time. No monetary in-
centives were offered.
Survey administration
After receiving confirmation of participation in the re-
search project, we sent an email containing the anon-
ymized link to access the online questionnaire.
The questions in our survey were not randomized or
alternated. Only the first question of the survey (Does
your agency conduct rapid reviews (RRs) of diagnostic
tests?) was mandatory; a negative answer to this question
terminated the survey because the responder was deemed
not to have the experience needed to answer the remaining
questions.
Participants could review and modify their answers be-
fore submission using the back button. All responses
were entered via the internet and automatically cap-
tured. Multiple entries from the same IP address were
not allowed while the survey was open.
Data analysis and ethical issues
This study was exempt from requiring approval by our
Ethics Committee in accordance with Spanish National
Regulations. A positive response to the invitation email
was considered to be an agreement/informed consent to
participate in the study.
Survey responses were de-identified and anonymized
for all analyses. Duplicate entries were eliminated before
analysis; only the final entry was kept for further ana-
lyses. Incomplete surveys were not included in the final
analysis. We did not use the time spent to complete the
survey as a criterion to exclude answers (questionnaires
submitted with an atypical timestamp). We did not rely
on statistical methods for assessing representativeness of
the final sample. We performed all descriptive analysis
using STATA 15.0.
Results
Data were collected from April to July 2019. A total of
74 institutions were contacted by email, and we received
39 replies (53% response rate). The responders were lo-
cated in Europe (20 agencies; 52%), America (11 agen-
cies; 28%), Asia (4 agencies; 10%), Africa and Australia
(2 agencies each one; 5% respectively). All but one of the
institutions that had initially agreed to participate com-
pleted the survey (97% participation rate). The average
time to complete the survey was around 11min.
Twenty-five (64%) of the 39 participants indicated that
they performed RRs of diagnostic tests. They formed the
final sample for our following analyses. The characteris-
tics of participants (n = 25) are shown in Table 1.
The median number of RRs of diagnostic tests com-
pleted per institution at the time of the survey was 10
(Interquartile range from 5 to 18). Three institutions
performed more than 100 RRs. Nine institutions indi-
cated the use of a handbook or guideline to develop RRs
(36%). Twenty-two institutions reported that these RRs
are developed within a constrained time schedule (88%).
In addition, the involvement of highly trained staff was a
frequent element of RR conduct at participating institu-
tions (88%). However, less than half of the institutions
involved more than two reviewers or more than one
team (i.e. to address different types of evidence, such as
health outcomes and cost-effectiveness) during the per-
formance of RRs (10 agencies; 40%). Ten agencies re-
ported active participation of stakeholders during the
development of RRs (40%; Table 1).
With regards to the general methods involved in the
performance of RRs, 16 institutions developed and
followed a protocol (64%). Most institutions reported a re-
vision of the RR findings by an external and/or internal
peer-review process (24 institutions; 96%). Only eleven in-
stitutions considered publishing the final RR (Table 1).
Table 1 Characteristics of participating institutions
Country N (%)
Africa 1 (4)
America 9 (36)
Asia 3 (12)
Europe 11 (44)
Oceania 1 (4)
Number of RRs of diagnostic tests developed
Less than 10 RR 10 (40)
10 to 30 RR 9 (36)
More than 30 RR 6 (24)
Availability of RR methodological guidance (i.e. handbook)
Yes 9 (36)
Structure of RRs team
High level of training 22 (88)
Involvement of more than two reviewers or more than
one team
10 (40)
Stakeholder involvement in several activities 10 (40)
General methods of RRs
Development of a protocol 16 (64)
Use of a reporting template 12 (48)
Peer-review process 24 (96)
Public consultation of the draft review 4 (33)
Publication of the final review 11 (44)
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Methods used to establish the scope of the review
All participants reported the implementation of one or
more methods to pre-define the scope of a RR during
the planning stage (range from 1 to 7 methods). A con-
siderable number of participants reported implementing
actions related to planning such as defining a structured
PICO question (92%) and discussing the clinical pathway
and the target condition with stakeholders (i.e., the role
of the test in current practice and the intended applica-
tions) (68%). Only eleven participants reported limiting
the number of outcomes (44%). All but one agency in-
cluded accuracy as one of the main outcomes assessed
in the development of RR of diagnostic tests (96%). Only
one strategy was used by more than 90% of participants:
defining a structured PICO question. One participant re-
ported an additional method to narrow the scope of the
RR: limiting the reference standards accepted for the tar-
get condition (Table 3).
Methodological shortcuts
All participants reported the use of one or more methodo-
logical shortcuts when developing a RR of a diagnostic test
(range from 4 to 13 methods) with six institutions report-
ing the use of up to five different shortcuts. The most
common strategy was the use of a previous review as a
starting point (e.g., to update the findings or to replicate
the electronic searches; 92%) followed by limiting search
strategies by language (e.g., to English only; 84%), and ex-
cluding additional sources of evidence such as conference
proceedings (88%). Twenty-four participants reported
using two or more limits when conducting search strat-
egies (96%). In addition, nine agencies reported perform-
ing the screening, final selection, data abstraction, and
quality appraisal with only one reviewer (36%) (Table 2).
An important number of participants did not perform
a meta-analysis in RRs (76%) nor assessed the certainty
of evidence (60%). Participants suggested two additional
methodological shortcuts that were not included in our
survey: partial verification of the screening, final selec-
tion, data extraction, and quality assessment by a second
reviewer; and the choice of pre-existing evidence synthe-
sis as the only eligible source of evidence (i.e. no primary
studies are included) (Table 3).
Parallelization of tasks
Twelve participants reported using one or more strat-
egies to parallelize review tasks (48%) while three of
these participants used all parallelization methods de-
scribed in the survey. The two most frequently used
strategies were the involvement of several reviewers in
the screening of citations and quality appraisal (eight
agencies; 32%) (Table 2). One participant reported that
parallelization could also be used to assess the certainty
of evidence using the GRADE approach. Another
participant reported parallelization of review activities by
performing selected activities simultaneously instead of
consecutively (such as data extraction of known studies
while a search of new studies is conducted) (Table 3).
Automation of review tasks
Algorithms and machine learning techniques are
methods rarely used by participating institutions. Only
five participants reported the use of one or more of
these techniques to perform RR tasks. Three agencies
Table 2 Rapid review methods reported by the survey participants
Method N (%)
Narrow the scope
Defining a structured PICO question 23 (92)
Discussing the clinical pathway for the target condition a 17 (68)
Limiting the population b 17 (68)
Limiting the number of index tests c 19 (76)
Limiting the number of comparisons d 14 (56)
Limiting the number of outcomes e 11 (44)
Limiting the number of applications of the tests f 20 (80)
Review shortcuts
Using a previous review as a starting point g 23 (92)
Limiting search strategies to one database 2 (8)
Limiting search strategies by language 21 (84)
Limiting search strategies by date 17 (68)
Limiting the syntax of search strategies h 8 (32)
Limiting search strategies results using methodological filters 14 (56)
Excluding additional searches i 22 (88)
Limiting screening of titles & abstracts: one reviewer only 12 (48)
Limiting the selection of full texts: one reviewer only 15 (60)
Limiting the data abstraction: one reviewer only 16 (64)
Limiting the quality appraisal: one reviewer only 10 (40)
Performing a narrative synthesis of findings j 19 (76)
Excluding a GRADE assessment of findings 15 (60)
Parallelization of tasks
Multiple reviewers completing the eligibility screening 8 (32)
Multiple reviewers completing the data abstraction 7 (28)
Multiple reviewers completing the quality appraisal 8 (32)
Automation
Used to assist in the screening/selection of references 3 (12)
Used to assist in the data abstraction 2 (8)
Used to assist in the quality appraisal 1 (4)
Notes: a including the role of the test in the current clinical practice, its
intended application, and prior/alternative tests; b ideally to one single
population; c ideally to one single test; d ideally to one single comparison; e
ideally to one single outcome; f ideally to one single application: i.e.
monitoring, screening, diagnosis; g i.e. stepwise approach with an emphasis on
higher levels of evidence, update of existing SR, re-run search strategies; h, e.g.
focused subject headings, terms in title only; i, e.g. conference abstracts;
search on the internet; j instead of a meta-analysis of data
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reported the use of software to assist in the screening
and selection of references (11%; Table 2).
Discussion
To the best of our knowledge, this is the first inter-
national survey assessing current practice of methods for
diagnostic test RRs. With 25 participants from across all
continents, we managed to generate a broad inter-
national sample. We obtained additional information
about current strategies in use for development of these
RRs in order to complement the findings from our pre-
vious scoping review [20].
Briefly, the general methods involved for the develop-
ment of RR can be broadly classified into two groups:
those limiting the scope and/or affecting the rigor of RR
development; and those increasing the resources avail-
able for RR development [5, 6, 24, 25]. In the first group,
we found that most strategies to narrow the scope are
not used as a standard method; however, our survey in-
dicated a greater usage of limits in the scope than our
previous scoping review suggested [20]. In addition, we
found a high number of participants imposing limits on
the search, e.g., by limiting the language or date of elec-
tronic searches. We noticed that more than half of re-
spondents use methodological filters during the
literature search indicating that respondents are willing
to potentially miss some studies in order to retrieve a
manageable number of search results given the project’s
shortened timeframe [17, 18]. We also confirmed that
the participants often use a narrative synthesis to de-
scribe their findings rather than a formal data meta-
analysis [20]. Participants also reported that they con-
sider the inclusion of previous evidence synthesis to be
useful for streamlining. While the use of pre-existing re-
views was one strategy proposed for development of
RRs, it is important to note that this strategy depends on
the availability of existing SRs that satisfy the updated
standards of preferred reporting items [26–28]. These
may not exist for all topics.
Regarding the resources available for RR development,
we found that a considerable number of institutions in-
volved trained staff in the development of diagnostic
RRs although there were usually only two reviewers in-
volved. Selection and data abstraction by a single re-
viewer were common; however, it is possible that some
institutions may prefer to perform selective verification
by a second reviewer on a sample of the total citations.
This strategy was suggested by the survey’s participants.
We found that roughly one-third of institutions involved
stakeholders in the development of RRs. While most
standard SRs do not involve stakeholders in their pro-
duction, RRs might be more relevant for decision-
making in certain situations [29–31]. We further found
limited use of task parallelization perhaps due to the lack
of studies about the usability and impact of these strat-
egies both in general and for diagnostic test RRs in par-
ticular [32–34].
Previous surveys of producers of knowledge syntheses
reported slightly higher levels of adoption of RR
methods compared to our findings [35]. These levels of
adoption are also higher than those found in our previ-
ous scoping review. It is possible that RRs using methods
similar to those used in SRs have a greater chance of be-
ing published [24, 36]. While we found that few RR
methods are used by more than 90% of participants, we
also observed that some SR tasks—such as developing a
protocol and performing peer-review—are commonly
implemented despite the time required for implementa-
tion. One possible explanation for this is that the extent
of methodological modifications relies on a request from
different stakeholders and therefore, in some cases, RRs
can be produced following many of the same methods
used in standard SRs [20, 37]. In addition, it is known
that decision-makers are willing to accept only a small
Table 3 Additional rapid review methods reported by the survey participants
New methodologies Comments
Establishing the scope Limiting the accepted reference standards Ideally to a single reference standard
Limitations and shortcuts Selecting pre-existing synthesis of evidence only e.g., systematic reviews, HTA reports
Screening of titles & abstracts: selected verification Two reviewers involved, checking a sample of/all references
for accuracy
Selection of full texts performed: selected verification Two reviewers involved, checking a sample of/all references
for accuracy
Data abstraction: selected verification Two reviewers involved, checking the sample/all references
for accuracy
Quality appraisal: selected verification Two reviewers involved, checking the sample/all references
for accuracy
Parallelization and
automation
Multiple reviewers assessing the certainty of the
evidence
i.e. using the GRADE approach
Performing selected review activities simultaneously e.g., data extraction of known studies while a search of new
studies is conducted
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risk for an inaccurate answer in exchange for a rapid prod-
uct; thus, current RR developers would be reluctant to
compromise the validity of results in exchange for imple-
mentation of methodological shortcuts and limits [37, 38].
We acknowledge several potential limitations in this
study. The descriptive goal of our research do not involve
specialized statistical analysis. We obtained a 53% response
rate from invited institutions based around the world; non-
responders were located mainly in Europe and Latin Amer-
ica. Although we obtained replies from institutions based in
similar locations, these missing data could have generated a
risk of selection bias in our findings. We also found that 13
out of 39 institutions replying to our invitation do not con-
duct RRs and/or RRs of diagnostic tests. Also, participants
in our survey were mainly representatives of local, national,
and regional HTA agencies. The reports performed by
these institutions might have characteristics that differ from
other reviews (i.e. classic systematic reviews) produced in
academic and research settings.
Conclusions
To the best of our knowledge, this is the first inter-
national survey assessing the current practice of
methods for diagnostic test RRs. Our survey indicates a
greater use of shortcuts and limits versus our previous
scoping review findings that was based on published RRs
of diagnostic tests.
However, while our findings suggest that SR methods are
sometimes preserved in the current practice of diagnostic
test RRs, more general RR methods are usually applied to
diagnostic evidence without a structured evaluation of the
impact of their implementation. Nevertheless, due to the
different characteristics of evidence synthesis used with
diagnostic tests, there is a need to evaluate the commonly
used methodological shortcuts specific to data sets com-
prising the RR on diagnostic tests as other researchers have
claimed for their own fields [24]. In order to investigate this
further, the next stage of our work is to conduct a series of
interviews with experts in the diagnostic field to explore the
potential challenges and implications of the adoption of
these RR methods [21]. The findings of our research pro-
gram on the RRs of diagnostic tests will be useful for the
development of clear and tailored guidance in this field as
well as to provide recommendations about adequate
methods for rapid synthesis of diagnostic evidence for
decision-making and policy development.
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